How certain inhibitory brain cells help form new location memories in healthy people and in Alzheimer's

Hippocampal interneurons in novel memory formation in health and Alzheimer's disease

NIH-funded research Georgia Institute of Technology · NIH-11297634

This work looks at whether a type of inhibitory brain cell called parvalbumin interneurons helps form precise spatial memories in healthy brains and in Alzheimer's disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionGeorgia Institute of Technology NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11297634 on NIH RePORTER

What this research studies

Researchers will use lab models of Alzheimer’s disease to record the electrical activity of many inhibitory and excitatory hippocampal neurons at once while subjects learn new locations. They will use cell-type specific, time-precise tools to stimulate and quiet parvalbumin (PV) interneurons to see how those manipulations change memory formation. The goal is to map how PV interneuron activity helps create precise spatial maps and how Alzheimer's pathology, like elevated amyloid beta, disrupts that process. Findings will guide whether targeting inhibitory circuits could help restore memory function in Alzheimer's.

Who could benefit from this research

Good fit: This project does not appear to enroll patients directly, but people with early-stage Alzheimer's disease or early spatial memory impairments would be the kind of patients who might benefit from later clinical trials based on these findings.

Not a fit: Patients with very advanced Alzheimer's or memory loss from non-Alzheimer causes are less likely to see direct benefit from this preclinical work in the short term.

Why it matters

Potential benefit: If successful, this work could point to new ways to restore inhibitory cell function and improve memory in people with Alzheimer's disease.

How similar studies have performed: Prior animal studies link inhibitory interneuron deficits to memory problems, but precise, cell-type specific manipulation of PV interneurons in Alzheimer's models is a relatively new and developing approach.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.